SCI
GILD icon

SkyBridge Capital II’s Gilead Sciences GILD Stock Holding History

SkyBridge Capital II’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-103,780
Closed -$7.82M – 32
2018
Q1 		$7.82M Sell
103,780
-37,448
-27% -$2.98M 3.8% 7
2017
Q4 		$10.1M Sell
141,228
-29,344
-17% -$2.23M 3.36% 13
2017
Q3 		$13.8M Sell
170,572
-36,330
-18% -$2.78M 4.03% 4
2017
Q2 		$14.6M Buy
+206,902
New +$13.8M 3.51% 10

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SkyBridge Capital II's GILD Position: Q2 2018 in Review

SkyBridge Capital II sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 103,780 shares — an estimated $7.82M sold.

SkyBridge Capital II first reported a position in GILD in Q2 2017 and held it in 4 quarters. The position peaked at $14.6M in Q2 2017. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • SkyBridge Capital II reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • SkyBridge Capital II sold 103,780 Gilead Sciences shares in Q2 2018, an estimated $7.82M.
  • SkyBridge Capital II first reported a position in Gilead Sciences in Q2 2017 and held it in 4 quarters.
  • SkyBridge Capital II's Gilead Sciences position peaked at $14.6M in Q2 2017.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on SkyBridge Capital II's 13F filing for Q2 2018, filed 14 Aug 2018.